Publications by authors named "Mark Aeder"

Claim this Profile
I
Improving Resident-To-Attending Communication: Implementing a Tool to Facilitate Attending Notification of Critical Patient Events at a Single Academic Institution.
Zachary J Senders, Mark Aeder, Susan Semrau, John Ammori

Am Surg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-day readmission after ventral hernia repair: predictable or preventable?
Jeffrey A Blatnik, Karem C Harth, Mark I Aeder, Michael J Rosen

Surg Endosc· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients.
Joshua J Augustine, Emilio D Poggio, Michael Clemente, Mark I Aeder, Kenneth A Bodziak

J Am Soc Nephrol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a nationalized, multiregional Paired Donation Network.
E Steve Woodle, David Goldfarb, Mark Aeder, Tanmay Lal, Adele Rike

Clin Transpl· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus.
Donald E Hricik, Joshua J Augustine, Thomas C Knauss, Kenneth A Bodziak, Mark Aeder

Transplantation· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis.
Christopher F Bryan, Scott B McDonald, Alan M Luger, Charles F Shield, Franz T Winklhofer, Mark I Aeder

Clin Transplant· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients.
Joshua J Augustine, Peter C Chang, Thomas C Knauss, Mark I Aeder, Kenneth A Bodziak

Transplantation· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk for Chagas' disease in the Midwestern United States organ donor population is low.
Christopher F Bryan, Gary E Tegtmeier, Nour Rafik, Lori E Markham, Daniel Murillo, Mark I Aeder

Clin Transplant· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.
Christopher F Bryan, Wida S Cherikh, Yulin Cheng, Mark I Aeder, Nicolas A Muruve

Clin Transplant· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects.
Thomas G Peters, Kristin N Spinola, John C West, Mark I Aeder, Gabriel M Danovitch

Transplantation· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors.
Christopher F Bryan, Kevin M Harrell, Stanley I Mitchell, Bradley A Warady, Mark I Aeder

Am J Transplant· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates.
Christopher F Bryan, Scott B McDonald, Karen A Baier, Alan M Luger, Mark I Aeder

Clin Transplant· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system?
Paul W Nelson, Charles F Shield, Nicolas A Muruve, Daniel Murillo, Bradley A Warady, Mark I Aeder

Am J Transplant· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis